kabutan

StemCell Institute(7096) Summary

7096
TSE Growth
StemCell Institute
823
JPY
-5
(-0.60%)
Jan 29, 3:30 pm JST
5.38
USD
Jan 29, 1:30 am EST
Result
PTS
outside of trading hours
821.1
Jan 29, 9:18 am JST
Summary Chart Historical News Financial Result
PER
25.9
PBR
3.18
Yield
ー%
Margin Trading Ratio
12.69
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
828 JPY 5.40 USD
Previous Close Jan 28
828 JPY 5.42 USD
High Jan 29, 9:00 am
828 JPY 5.40 USD
Low Jan 29, 9:18 am
818 JPY 5.34 USD
Volume
6,200
Trading Value
5.00M JPY 0.03M USD
VWAP
821.74 JPY 5.37 USD
Minimum Trading Value
82,300 JPY 538 USD
Market Cap
8.43B JPY 0.06B USD
Number of Trades
38
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
Mid
1-Year Average
194
1-Year High Jul 16, 2025
5,341
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 27,400 289,500 10.57
Jan 16, 2026 28,100 291,600 10.38
Jan 9, 2026 32,500 302,700 9.31
Dec 26, 2025 35,700 334,900 9.38
Dec 19, 2025 38,500 337,500 8.77
Company Profile
StemCell Institute operates a cell bank business for regenerative medicine, focusing on the separation and storage of umbilical cord blood. It is part of the Nihon Trim Group.
Sector
Services
StemCell Institute develops a cell bank business for regenerative medicine and cell therapy. The company separates and stores cells derived from perinatal tissues such as umbilical cord blood and umbilical cords for future medical treatments. Umbilical cord blood contains hematopoietic stem cells and mesenchymal cells, and clinical research is progressing on regenerative medicine and cell therapy for pediatric central nervous system diseases and autism spectrum disorders. StemCell Institute has cell processing centers in Tokyo and Yokohama, and a cell storage center in Yokohama, with various certifications including a license for manufacturing specific cell products. In addition to umbilical cord blood storage, the company has also launched umbilical cord tissue storage services. StemCell Institute is also engaged in the development of regenerative medicine products and business development and investment in related fields.